These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Zhang D, Fan D. Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563 [Abstract] [Full Text] [Related]
3. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Cancer Invest; 2008 May 21; 26(4):344-51. PubMed ID: 18443954 [Abstract] [Full Text] [Related]
6. The great multidrug-resistance paradox. Chen VY, Rosania GR. ACS Chem Biol; 2006 Jun 20; 1(5):271-3. PubMed ID: 17163753 [Abstract] [Full Text] [Related]
8. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A, Seth K, Kalra N, Shukla Y. Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829 [Abstract] [Full Text] [Related]
10. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases. Sivapackiam J, Gammon ST, Harpstrite SE, Sharma V. Methods Mol Biol; 2010 Feb 01; 596():141-81. PubMed ID: 19949924 [Abstract] [Full Text] [Related]
16. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B. Pharmazie; 2008 Jul 27; 63(7):528-33. PubMed ID: 18717489 [Abstract] [Full Text] [Related]
19. Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception. Monceviciute-Eringiene E. J Exp Clin Cancer Res; 2000 Sep 27; 19(3):335-48. PubMed ID: 11144527 [Abstract] [Full Text] [Related]
20. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Hepatogastroenterology; 2008 Sep 27; 55(86-87):1530-6. PubMed ID: 19102336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]